1 June 2000 in Cell Proliferation
Sodium butyrate (NaB), a product of colonic fermentation of dietary fibre, has been shown to inhibit cell proliferation by blocking cells in the G0/G1 phase of the cell cycle through a mechanism of action still not completely understood. We investigated the effect of NaB on the level of some G1 phase‐related proteins in a colon carcinoma cell line (HT29). In particular, we addressed our attention to cyclin D1 (the key regulator of G1S progression), p21waf1/cip1 (the main inactivator of the cyclin D/cdk complex), and p53 (the most important regulator of p21waf1/cip1 gene transcription). At inhibitory concentrations (higher than 1 mM) NaB reduced cyclin D1 and p53 level in a dose‐dependent manner and sustained the synthesis of p21waf1/cip1, probably in a p53‐independent way, accounting for the G0/G1 block observed by flow cytometry. Present results provide further evidence on the molecular mechanism at the basis of the physiological role of NaB and support the hypothesis that an unbalanced diet, poor in carbohydrates and therefore in NaB, could result in functional alterations with clinical and carcinogenic implications.
1 October 2013 in Colloids and Surfaces B: Biointerfaces
1 March 2001 in International Journal of Cancer
To elucidate the mechanism of action of sodium butyrate (NaB), we examined its effect on the expression of some cell cycle‐related proteins (cyclins D1 and E, p16ink4, p21waf1, p27kip1) in 2 human non‐small cell lung cancer cell lines (NCI‐460 and NCI‐H23) characterized by wild‐ type and mutant TP53, respectively. The growth of both cell lines was inhibited in a dose‐dependent manner and this process was accompanied by a modulation of cell cycle‐related proteins. In NCI‐H460, the p27kip1 and p16ink4 protein levels were markedly increased following NaB treatment, whereas p21waf1 was only slightly elevated, with a peak at 2 mM NaB, and p53 was unaffected by any concentration. By contrast, in NCI‐H23, a marked increase in p21waf1 protein was paralleled by decreased p53 levels, whereas all the other investigated proteins remained stable. The results suggest that NaB blocks the growth of both cell lines by induction of cyclin‐dependent kinase inhibitors (in particular, p21waf1 in NCI‐H23 and p27kip1 and p16ink4 in NCI‐H460) through a p53‐dependent or p53‐independent mechanism, and open up interesting perspectives for the use of NaB as an alternative or additional strategy in the treatment of non‐small cell lung carcinoma.
1 August 2004 in Investigational New Drugs
27 August 1999 in British Journal of Cancer
Mechanisms of resistance to Tomudex include increased thymidylate synthase activity, as well as reduced intracellular drug uptake and polyglutamation. However, little is known about other mechanisms of resistance, such as a possible protection against Tomudex-induced apoptosis mediated by bcl-2. We transfected the MDA-MB-435 human breast cancer cell line, which is characterized by a mutated p53 gene, with cDNA of the bcl-2 gene and generated two clones (MDA-bcl4 and MDA-bcl7) characterized by bcl-2 expression twofold and fourfold that observed in the control cell clone (MDAneo). A concomitant overexpression of p21wafl was also detected in the MDA-bcl7 clone. The MDA-bcl4 clone was three times more resistant to a 24-h Tomudex exposure than the MDAneo clone, whereas the MDA-bcl7 clone was as sensitive to Tomudex as the control cell clone. A lower sensitivity of the MDA-bcl4 clone than MDAneo and MDA-bcl7 clones to 5-fluorouracil and gemcitabine was also observed. No significant difference was noted in the susceptibility of clones to fludarabine and methothrexate. Basal levels of thymidylate synthase activity were superimposable in the three clones. Tomudex induced a marked accumulation of cells in the S phase in all the clones. However, an apoptotic hypodiploid DNA peak and the characteristic nuclear morphology of apoptosis were observed only in the MDA-bcl7 clone after exposure to Tomudex. No difference in the treatment-induced modulation of proteins involved in cell cycle progression (cyclin A, cdk2, pRB, E2F-1) and apoptosis (bcl-2, bax) was observed in the three clones. The only exception was that the expression of p21wafl in the MDA-bcl4 clone was inducible at a Tomudex concentration much higher than that required to induce the protein in the other clones. Overall, the results indicate that bcl-2 and p21wafl proteins concur in determining the cellular profile of sensitivity/resistance to Tomudex.
1 March 2001 in European Journal of Cancer